Literature DB >> 31724220

Long non-coding RNA FENDRR restrains the aggressiveness of CRC via regulating miR-18a-5p/ING4 axis.

Sheng Lu Yin1, Fei Xiao1, Yong Fu Liu1, Hao Chen1, Guan Cheng Guo1.   

Abstract

There is increasing evidence has indicated that long non-coding RNAs (lncRNAs) are implicated in the tumorigenesis and development of colorectal cancer (CRC). Nevertheless, the clinical significances and functions of FENDRR in CRC remain unknown. In this study, we reveal that lncRNA FENDRR is downregulated in CRC and negatively correlated with advanced stage and poor clinical outcomes of patient with CRC. Overexpression of FENDRR represses the proliferation, migrate and invasive capacities of CRC cell in vitro, and upregulation of FENDRR inhibits the growth and distant metastatic capacity of CRC cell in vivo. Mechanistically, FENDRR interacts with miRNA-18a-5p (miR-18a-5p) and subsequently regulates the expression of inhibitor of growth 4 (ING4) in CRC cell. Interestingly, ING4 repression or miR-18a-5p rescues FENDRR induced proliferation and aggressive phenotypes inhibition of CRC cell. Altogether, our findings suggest that FENDRR exerts an inhibitory role in CRC by interacting with miR-18a-5p and future increases ING4 expression.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  CRC; FEMDRR; ING4; miR-18a-5p

Year:  2019        PMID: 31724220     DOI: 10.1002/jcb.29555

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

Review 1.  Potentials of long non-coding RNAs as biomarkers of colorectal cancer.

Authors:  Yan Lv; Yanhua Wang; Zhikai Zhang; Jiarui Bao; Huahua Su
Journal:  Clin Transl Oncol       Date:  2022-05-17       Impact factor: 3.340

2.  Lung-specific distant enhancer cis regulates expression of FOXF1 and lncRNA FENDRR.

Authors:  Przemyslaw Szafranski; Tomasz Gambin; Justyna A Karolak; Edwina Popek; Paweł Stankiewicz
Journal:  Hum Mutat       Date:  2021-04-06       Impact factor: 4.700

3.  LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis.

Authors:  Wei Zhao; Jing Zhao; Xiao Guo; Yujie Feng; Bingyuan Zhang; Lantian Tian
Journal:  BMC Cancer       Date:  2021-02-08       Impact factor: 4.430

Review 4.  Long Non-Coding RNA FENDRR: Gene Structure, Expression, and Biological Relevance.

Authors:  Przemyslaw Szafranski; Paweł Stankiewicz
Journal:  Genes (Basel)       Date:  2021-01-27       Impact factor: 4.141

5.  LINC00963 affects the development of colorectal cancer via MiR-532-3p/HMGA2 axis.

Authors:  Jinjun Ye; Jidong Liu; Tao Tang; Le Xin; Xing Bao; Yukuang Yan
Journal:  Cancer Cell Int       Date:  2021-02-03       Impact factor: 5.722

Review 6.  MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets.

Authors:  Brian G Jorgensen; Seungil Ro
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

7.  Prognostic and Predicted Significance of FENDRR in Colon and Rectum Adenocarcinoma.

Authors:  Fan Yang; Siyu Sun; Fei Yang
Journal:  Front Oncol       Date:  2021-09-21       Impact factor: 6.244

8.  hTERT Promotes CRC Proliferation and Migration by Recruiting YBX1 to Increase NRF2 Expression.

Authors:  Chunli Gong; Huan Yang; Sumin Wang; Jiao Liu; Zhibin Li; Yiyang Hu; Yang Chen; Yu Huang; Qiang Luo; Yuyun Wu; En Liu; Yufeng Xiao
Journal:  Front Cell Dev Biol       Date:  2021-05-17

9.  miR-18a-5p Targets FBP1 to Promote Proliferation, Migration, and Invasion of Liver Cancer Cells and Inhibit Cell Apoptosis.

Authors:  Shan Gao; Dongjie Zhu; Jian Zhu; Lianqiang Shen; Ming Zhu; Xuefeng Ren
Journal:  Comput Math Methods Med       Date:  2021-06-14       Impact factor: 2.238

10.  Carbohydrate Sulfotransferase 4 Inhibits the Progression of Hepatitis B Virus-Related Hepatocellular Carcinoma and Is a Potential Prognostic Marker in Several Tumors.

Authors:  Longshan Zhang; Yao Fan; Xiaoqing Wang; Mi Yang; XiXi Wu; Weiqiang Huang; Jin Lan; Liwei Liao; Wenqi Huang; Lu Yuan; Hua Pan; Yuting Wu; Longhua Chen; Jian Guan
Journal:  Front Oncol       Date:  2020-10-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.